Glanbia falls 6% as Morgan Stanley cuts to underweight
Alpha Vantage · Yahoo Finance · · AI-summarised by FinFlash
Glanbia shares fell 6% after Morgan Stanley downgraded the Irish nutrition group to Underweight, citing intensifying competition and higher contracted whey costs. The bank cut its 12-month price target to €19.20, warning these factors could pressure 2027 margins and earnings. Morgan Stanley did raise its 2026 EPS estimate after Glanbia's Q3 beat.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.